Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD

Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic pathology in industrialized countries, affecting about 25% of the general population. NAFLD is a benign condition, however, it could evolve toward more serious diseases, including non-alcoholic steatohepatitis (NASH), fibrosis, cir...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Mauro, Stefania, Scamporrino, Alessandra, Filippello, Agnese, Di Pino, Antonino, Scicali, Roberto, Malaguarnera, Roberta, Purrello, Francesco, Piro, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585051/
https://www.ncbi.nlm.nih.gov/pubmed/34769333
http://dx.doi.org/10.3390/ijms222111905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585051/
https://www.ncbi.nlm.nih.gov/pubmed/34769333
http://dx.doi.org/10.3390/ijms222111905

Ejemplares similares